XELJANZ

Product NDC
63539-029
11-digit product format
635390029
Labeler code
63539
Product ID
63539-029_184c6caf-b874-4b42-9a0d-30219f3fd2ef
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
tofacitinib
Dosage form
SOLUTION
Route
ORAL
Labeler
U.S. Pharmaceuticals
Application
NDA213082
Marketing category
NDA
Marketing start
2021-02-08
Substance
TOFACITINIB CITRATE
Active strength
1 mg/mL
Pharmacologic classes
Janus Kinase Inhibitor [EPC], Janus Kinase Inhibitors [MoA]
NDC exclude flag
No
Listing certified through
2027-12-31
Current FDA listing
Yes

Additional Listing Data#

Finished product
Yes
Brand name base
XELJANZ
Listing expiration
2027-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
TOFACITINIB CITRATE1 mg/mL

Harmonized Identifiers#

Field, Values table
FieldValues
UniiO1FF4DIV0D
Rxcui1357541, 1357547, 1741046, 1741049, 2048566, 2048568, 2273113, 2273115, 2478433, 2478437

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
10e4c2fb-ffa2-728d-14d9-1c6c2f2b27b6Product name420250623
362d7abb-94e6-4c60-9a58-266894157713Product name120231023
816b97af-edc5-4060-aff1-b814bdbcad50Product name120190415
419aab54-5d5a-4146-9453-026d4a9991beProduct name220170525
89dac932-b90a-4410-9ab1-84c53e57de25Product name120150316
d723478e-ad4a-ec23-6bd7-cfe33e1e3840Product name120140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
63539-029-01XELJANZ240 mL in 1 BOTTLESOLUTION24017
63539-029-02XELJANZ1 in 1 CARTONSOLUTION117

DailyMed Socrata Ingredients#

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
2478433tofacitinib 1 MG/mL Oral SolutionPSN68e3d6b2-7838-4d2d-a417-09d919b43e1317
2048566tofacitinib 10 MG Oral TabletPSN68e3d6b2-7838-4d2d-a417-09d919b43e1317
1741046tofacitinib 11 MG 24HR Extended Release Oral TabletPSN68e3d6b2-7838-4d2d-a417-09d919b43e1317
2273113tofacitinib 22 MG 24HR Extended Release Oral TabletPSN68e3d6b2-7838-4d2d-a417-09d919b43e1317
1357541tofacitinib 5 MG Oral TabletPSN68e3d6b2-7838-4d2d-a417-09d919b43e1317
2478437Xeljanz 1 MG/mL Oral SolutionPSN68e3d6b2-7838-4d2d-a417-09d919b43e1317
2048568Xeljanz 10 MG Oral TabletPSN68e3d6b2-7838-4d2d-a417-09d919b43e1317
1357547Xeljanz 5 MG Oral TabletPSN68e3d6b2-7838-4d2d-a417-09d919b43e1317
1741049Xeljanz XR 11 MG 24HR Extended Release Oral TabletPSN68e3d6b2-7838-4d2d-a417-09d919b43e1317
2273115Xeljanz XR 22 MG 24HR Extended Release Oral TabletPSN68e3d6b2-7838-4d2d-a417-09d919b43e1317
174104924 HR tofacitinib 11 MG Extended Release Oral Tablet [Xeljanz]SBD68e3d6b2-7838-4d2d-a417-09d919b43e1317
227311524 HR tofacitinib 22 MG Extended Release Oral Tablet [Xeljanz]SBD68e3d6b2-7838-4d2d-a417-09d919b43e1317
2478437tofacitinib 1 MG/ML Oral Solution [Xeljanz]SBD68e3d6b2-7838-4d2d-a417-09d919b43e1317
2048568tofacitinib 10 MG Oral Tablet [Xeljanz]SBD68e3d6b2-7838-4d2d-a417-09d919b43e1317
1357547tofacitinib 5 MG Oral Tablet [Xeljanz]SBD68e3d6b2-7838-4d2d-a417-09d919b43e1317
174104624 HR tofacitinib 11 MG Extended Release Oral TabletSCD68e3d6b2-7838-4d2d-a417-09d919b43e1317
227311324 HR tofacitinib 22 MG Extended Release Oral TabletSCD68e3d6b2-7838-4d2d-a417-09d919b43e1317
2478433tofacitinib 1 MG/ML Oral SolutionSCD68e3d6b2-7838-4d2d-a417-09d919b43e1317
2048566tofacitinib 10 MG Oral TabletSCD68e3d6b2-7838-4d2d-a417-09d919b43e1317
1357541tofacitinib 5 MG Oral TabletSCD68e3d6b2-7838-4d2d-a417-09d919b43e1317
2048566tofacitinib 10 MG (as tofacitinib citrate 16 MG) Oral TabletSY68e3d6b2-7838-4d2d-a417-09d919b43e1317
1741046tofacitinib 11 MG (as tofacitinib citrate 17.77 MG) 24 HR Extended Release Oral TabletSY68e3d6b2-7838-4d2d-a417-09d919b43e1317
1741046tofacitinib 11 MG 24 HR Extended Release Oral TabletSY68e3d6b2-7838-4d2d-a417-09d919b43e1317
1357541tofacitinib 5 MG (as tofacitinib citrate 8 MG) Oral TabletSY68e3d6b2-7838-4d2d-a417-09d919b43e1317
2478437Xeljanz 1 MG/ML Oral SolutionSY68e3d6b2-7838-4d2d-a417-09d919b43e1317
2048568Xeljanz 10 MG (as tofacitinib citrate 16 MG) Oral TabletSY68e3d6b2-7838-4d2d-a417-09d919b43e1317
2048568Xeljanz 10 MG Oral TabletSY68e3d6b2-7838-4d2d-a417-09d919b43e1317
1357547Xeljanz 5 MG (as tofacitinib citrate 8 MG) Oral TabletSY68e3d6b2-7838-4d2d-a417-09d919b43e1317
1357547Xeljanz 5 MG Oral TabletSY68e3d6b2-7838-4d2d-a417-09d919b43e1317
1741049Xeljanz XR 11 MG (as tofacitinib citrate 17.77 MG) 24 HR Extended Release Oral TabletSY68e3d6b2-7838-4d2d-a417-09d919b43e1317
1741049Xeljanz XR 11 MG 24 HR Extended Release Oral TabletSY68e3d6b2-7838-4d2d-a417-09d919b43e1317
2273115Xeljanz XR 22 MG (as tofacitinib citrate 35.54 MG) 24 HR Extended Release Oral TabletSY68e3d6b2-7838-4d2d-a417-09d919b43e1317

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startSampleExclude flagStatus
63539-029-0163539002901240 mL in 1 BOTTLE240 mlHistorical
63539-029-02635390029021 BOTTLE in 1 CARTON (63539-029-02) / 240 mL in 1 BOTTLE (63539-029-01) 1 bottle2021-02-08NoNoCurrent